These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 16866649)
21. The susceptibility to tigecycline of Acinetobacter spp. may vary depending on the methodology used. Zárate MS; Serruto G; Smayevsky J Int J Infect Dis; 2010 Sep; 14 Suppl 3():e351-2. PubMed ID: 20031463 [No Abstract] [Full Text] [Related]
22. [Is sulbactam really the answer for treatment of infections caused by multiresistant strains of Acinetobacter spp.?]. Casellas JM; Dana R Enferm Infecc Microbiol Clin; 1997; 15(6):335-6. PubMed ID: 9376409 [No Abstract] [Full Text] [Related]
23. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia. Deris ZZ; Harun A; Shafei MN; Rahman RA; Johari MR Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):140-7. PubMed ID: 19323046 [TBL] [Abstract][Full Text] [Related]
24. [Characteristics of Acinetobacter strains isolated from a hospital environment. II. Drug resistance of Acinetobacter strains isolated from a hospital environment]. Bugalski R; Gospodarek E; Gołuszko P Med Dosw Mikrobiol; 1987; 39(2):118-23. PubMed ID: 3657328 [No Abstract] [Full Text] [Related]
25. Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalised patients in Greece and treatment implications. Falagas ME; Mourtzoukou EG; Polemis M; Vatopoulos AC; Clin Microbiol Infect; 2007 Aug; 13(8):816-9. PubMed ID: 17610601 [TBL] [Abstract][Full Text] [Related]
26. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains. Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994 [TBL] [Abstract][Full Text] [Related]
27. New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor. Schuelter-Trevisol F; Schmitt GJ; Araújo JM; Souza LB; Nazário JG; Januário RL; Mello RS; Trevisol DJ Rev Soc Bras Med Trop; 2016 Feb; 49(1):130-4. PubMed ID: 27163578 [TBL] [Abstract][Full Text] [Related]
28. Creating a cohort area to limit transmission of pandrug-resistant Acinetobacter baumannii in a Thai tertiary care center. Apisarnthanarak A; Warren DK; Fraser VJ Clin Infect Dis; 2009 May; 48(10):1487-8. PubMed ID: 19374565 [No Abstract] [Full Text] [Related]
29. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. Rodríguez Guardado A; Blanco A; Asensi V; Pérez F; Rial JC; Pintado V; Bustillo E; Lantero M; Tenza E; Alvarez M; Maradona JA; Cartón JA J Antimicrob Chemother; 2008 Apr; 61(4):908-13. PubMed ID: 18281693 [TBL] [Abstract][Full Text] [Related]
30. [Microbiological and therapeutic considerations of Acinetobacter spp. infection]. López-Brea M; Alarcón T; López S Rev Esp Quimioter; 1998 Jun; 11(2):110-7. PubMed ID: 9795295 [No Abstract] [Full Text] [Related]
31. [Intrathecal use of colistin]. Charra B; Hachimi A; Benslama A; Motaouakkil S Ann Fr Anesth Reanim; 2006 Feb; 25(2):215. PubMed ID: 16311006 [No Abstract] [Full Text] [Related]
32. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154 [TBL] [Abstract][Full Text] [Related]
33. Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas. Paramythiotou E; Karakitsos D; Aggelopoulou H; Sioutos P; Samonis G; Karabinis A Med Mal Infect; 2007 Feb; 37(2):124-5. PubMed ID: 17270377 [TBL] [Abstract][Full Text] [Related]
34. Characterisation of carbapenem-resistant Acinetobacter calcoaceticus--A. baumannii complex isolates in a third-level hospital in Bogotá, Colombia. Saavedra SY; Nuñez JC; Pulido IY; Gonzalez EB; Valenzuela EM; Reguero MT; Mantilla JR; Arango AI; Bravo P Int J Antimicrob Agents; 2008 Apr; 31(4):389-91. PubMed ID: 18308519 [No Abstract] [Full Text] [Related]
35. Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit. Longo B; Pantosti A; Luzzi I; Tarasi A; Di Sora F; Gallo S; Placanica P; Monaco M; Dionisi AM; Volpe I; Montella F; Cassone A; Rezza G Ann Ist Super Sanita; 2007; 43(1):83-8. PubMed ID: 17536158 [TBL] [Abstract][Full Text] [Related]
36. In vitro activity of tigecycline and other tetracyclines against carbapenem-resistant Acinetobacter species: report from a tertiary care centre in Karachi, Pakistan. Shakoor S; Khan E; Zafar A; Hasan R Chemotherapy; 2010; 56(3):184-9. PubMed ID: 20551633 [TBL] [Abstract][Full Text] [Related]
37. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics]. Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430 [TBL] [Abstract][Full Text] [Related]
38. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam. Pachón-Ibáñez ME; Fernández-Cuenca F; Docobo-Pérez F; Pachón J; Pascual A J Antimicrob Chemother; 2006 Sep; 58(3):689-92. PubMed ID: 16870647 [TBL] [Abstract][Full Text] [Related]
40. Association between antibiotic usage and subsequent colonization or infection of extensive drug-resistant Acinetobacter baumannii: a matched case-control study in intensive care units. Tsai HT; Wang JT; Chen CJ; Chang SC Diagn Microbiol Infect Dis; 2008 Nov; 62(3):298-305. PubMed ID: 18707839 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]